N-[4-(4-morpholinyl)butyl]-2-benzofurancarboxamide has been researched along with Cognitive Dysfunction in 1 studies
CL82198: a selective inhibitor of MMP13
Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, BL | 1 |
| Long, Y | 1 |
| Luo, W | 1 |
| Yan, Z | 1 |
| Lai, YJ | 1 |
| Zhao, LG | 1 |
| Zhou, WH | 1 |
| Wang, YJ | 1 |
| Shen, LL | 1 |
| Liu, L | 1 |
| Deng, XJ | 1 |
| Wang, XF | 1 |
| Sun, F | 1 |
| Chen, GJ | 1 |
1 other study available for N-[4-(4-morpholinyl)butyl]-2-benzofurancarboxamide and Cognitive Dysfunction
| Article | Year |
|---|---|
MMP13 inhibition rescues cognitive decline in Alzheimer transgenic mice via BACE1 regulation.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; As | 2019 |